Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395642 · ClinicalTrials.gov registry record · Phase 4
TRIAGE-CRT Telemonitoring in Patients With CHF and Indication of CRT-D
A Phase 4 study, sponsored by Biotronik.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT00395642 is a Phase 4 study that has completed, run by Biotronik. The registered enrollment target is 66 participants.
The verdict
NCT00395642, a Phase 4 study, has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
This feasibility study will investigate the clinical benefit of the combined use of BIOTRONIK Home Monitoring (HM) and weight and blood pressure (BP) external telemonitoring (ETM) in the follow-up treatment of patients implanted with a Cardiac Resynchronization Therapy Implantable Cardioverter Defibrillator (CRT-D). The feasibility study is designed to plan and define endpoints for a larger randomized study. The study will assess the HM-parameter trends correlation with daily weight and blood pressure changes. The patient compliance rate of the two different telemonitoring systems (HM \& ETM) will also be evaluated.
Interventions
- DEVICE Kronos LV-T, Lumax HF-T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395642
The ClinicalTrials.gov registry entry for NCT00395642 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kronos LV-T, Lumax HF-T is the first listed.
NCT00395642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00395642 about?
NCT00395642 is a clinical study titled "TRIAGE-CRT Telemonitoring in Patients With CHF and Indication of CRT-D". This feasibility study will investigate the clinical benefit of the combined use of BIOTRONIK Home Monitoring (HM) and weight and blood pressure (BP) external telemonitoring (ETM) in the follow-up treatment of patients implanted with a Cardiac Resynchronization Therapy Implantable Cardioverter Defib...
What is the current status of trial NCT00395642?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2006-11. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00395642?
The interventions under investigation include: Kronos LV-T, Lumax HF-T (DEVICE).
Who is sponsoring clinical trial NCT00395642?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.